Activating Effect of Benzbromarone, a Uricosuric Drug, on Peroxisome Proliferator-Activated Receptors
2007

Effects of Benzbromarone on PPARs

publication Evidence: moderate

Author Information

Author(s): Kunishima Chiyoko, Inoue Ikuo, Oikawa Toshihiro, Nakajima Hiromu, Komoda Tsugikazu, Katayama Shigehiro

Primary Institution: Torii Pharmaceutical Co., Ltd.

Hypothesis

Does benzbromarone activate peroxisome proliferator-activated receptors (PPARs) and induce peroxisome proliferation?

Conclusion

Benzbromarone induces peroxisome proliferation in hepatocytes by binding to PPARs and regulating lipid metabolism.

Supporting Evidence

  • Benzbromarone has been shown to bind to PPARα and PPARγ.
  • It promotes the binding of PPARs to peroxisome proliferator-responsive elements.
  • The drug increases the expression of proteins related to lipid metabolism.

Takeaway

Benzbromarone is a drug that can help lower uric acid but may also cause liver changes by affecting certain proteins that help process fats.

Methodology

The study examined the binding affinity of benzbromarone for PPARα and PPARγ using reporter gene assays, electric mobility shift assays, and Western blot analysis.

Limitations

The in vitro results may not directly translate to clinical use due to lower concentrations of benzbromarone in humans.

Digital Object Identifier (DOI)

10.1155/2007/36092

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication